Synergistic Interactions of Indole-2-Carboxamides and β-Lactam Antibiotics against Mycobacterium abscessus
- 21 April 2020
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 64 (5)
Abstract
New drugs or therapeutic combinations are urgently needed against Mycobacterium abscessus . Previously, we demonstrated the potent activity of indole-2-carboxamides 6 and 12 against M. abscessus . We show here that these compounds act synergistically with imipenem and cefoxitin in vitro and increase the bactericidal activity of the β-lactams against M. abscessus . In addition, compound 12 also displays synergism with imipenem and cefoxitin within infected macrophages.Keywords
Funding Information
- LabEx EpigenMed (ANR-10-LABX-12-01)
- Association Vaincre la Mucoviscidose (RIF20180502320)
This publication has 25 references indexed in Scilit:
- Mycobacterium abscessuspulmonary disease: individual patient data meta-analysisEuropean Respiratory Journal, 2019
- In Vitro Activity of the New β-Lactamase Inhibitors Relebactam and Vaborbactam in Combination with β-Lactams against Mycobacterium abscessus Complex Clinical IsolatesAntimicrobial Agents and Chemotherapy, 2019
- Indole-2-Carboxamides Are Active against Mycobacterium abscessus in a Mouse Model of Acute InfectionAntimicrobial Agents and Chemotherapy, 2019
- In Vitro and Intracellular Activity of Imipenem Combined with Rifabutin and Avibactam against Mycobacterium abscessusAntimicrobial Agents and Chemotherapy, 2018
- Antimicrobial resistance in Mycobacterium abscessus complex isolated from patients with skin and soft tissue infections at a tertiary teaching hospital in TaiwanJournal of Antimicrobial Chemotherapy, 2017
- Indole-2-carboxamide-based MmpL3 Inhibitors Show Exceptional Antitubercular Activity in an Animal Model of Tuberculosis InfectionJournal of Medicinal Chemistry, 2016
- US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis: executive summaryThorax, 2015
- In vitro evaluation of a new drug combination against clinical isolates belonging to the Mycobacterium abscessus complexClinical Microbiology and Infection, 2014
- In vitro efficacy of imipenem in combination with six antimicrobial agents against Mycobacterium abscessusInternational Journal of Antimicrobial Agents, 2007
- Synergy, antagonism, and what the chequerboard puts between themJournal of Antimicrobial Chemotherapy, 2003